Menu
Back to User profile » Prof. Dr. Gang Chen
Papers published by Prof. Dr. Gang Chen:
Metagenomic Next-Generation Sequencing Assists in the Diagnosis of Mediastinal Aspergillus fumigatus Abscess in an Immunocompetent Patient: A Case Report and Literature Review
Deng W, Jiang Y, Qin J, Chen G, Lv Y, Lei Y, Luo J, Hong K, Huang B, Qin L, Tang X, Ye L, Dang Y, Wang C, Long F, Wang K, Kong J
Infection and Drug Resistance 2023, 16:1865-1874
Published Date: 30 March 2023
AZGP1 Up-Regulation is a Potential Target for Andrographolide Reversing Radioresistance of Colorectal Cancer
Fang YY, Huang JM, Wen JY, Li JD, Shen JH, Zeng DT, Pan YF, Huang HQ, Huang ZG, Liu LM, Chen G
Pharmacogenomics and Personalized Medicine 2022, 15:999-1017
Published Date: 13 December 2022
Down-Regulation of Activating Transcription Factor 3 (ATF3) in Hepatoblastoma and Its Relationship with Ferroptosis
Li JX, Pang JS, Yin BT, Chen G, Chen JH, Luo JY, Yang X, Qin LT, Zeng JH, Chen P, Chen JB, Tang D
International Journal of General Medicine 2021, 14:9401-9418
Published Date: 6 December 2021
Clinical Significance and Effect of MTDH/AEG-I in Bladder Urothelial Cancer: A Study Based on Immunohistochemistry, RNA-Seq, and in vitro Verification [Retraction]
Zhang Y, Zhang LJ, Dang YW, Li SH, Yan HB, Chen G
Cancer Management and Research 2020, 12:461-462
Published Date: 21 January 2020
MIR22HG As A Tumor Suppressive lncRNA In HCC: A Comprehensive Analysis Integrating RT-qPCR, mRNA-Seq, And Microarrays
Gao L, Xiong D, He R, Yang X, Lai Z, Liu L, Huang Z, Wu H, Yang L, Ma J, Li S, Lin P, Yang H, Luo D, Dang Y, Chen G
OncoTargets and Therapy 2019, 12:9827-9848
Published Date: 18 November 2019
MiR-193a-3p inhibits pancreatic ductal adenocarcinoma cell proliferation by targeting CCND1
Chen ZM, Yu Q, Chen G, Tang RX, Luo DZ, Dang YW, Wei DM
Cancer Management and Research 2019, 11:4825-4837
Published Date: 27 May 2019
Identification and validation of an individualized autophagy-clinical prognostic index in bladder cancer patients
Wang SS, Chen G, Li SH, Pang JS, Cai KT, Yan HB, Huang ZG, He RQ
OncoTargets and Therapy 2019, 12:3695-3712
Published Date: 14 May 2019
The coexistence of a Wilms’ tumor and renal cell carcinoma in children: a case report and review of the literature
Zou XP, Jiang YY, Liao Y, Dang YW, Chen G, Feng ZB, Ma Y
OncoTargets and Therapy 2019, 12:953-958
Published Date: 30 January 2019
Clinical significance and effect of MTDH/AEG-1 in bladder urothelial cancer: a study based on immunohistochemistry, RNA-seq, and in vitro verification
Zhang Y, Zhang LJ, Dang YW, Li SH, Yan HB, Chen G
Cancer Management and Research 2018, 10:6921-6936
Published Date: 14 December 2018
Progression-free survival of up to 8 months of an advanced intrahepatic cholangiocarcinoma patient treated with apatinib: a case report
Ma FC, Yu Q, Zeng ZM, He RQ, Mo CH, Zhong JC, Ma J, Feng ZB, Chen G, Hu XH
OncoTargets and Therapy 2017, 10:5237-5242
Published Date: 1 November 2017
Role of downregulated miR-133a-3p expression in bladder cancer: a bioinformatics study
Gao L, Li SH, Tian YX, Zhu QQ, Chen G, Pang YY, Hu XH
OncoTargets and Therapy 2017, 10:3667-3683
Published Date: 20 July 2017
A comprehensive insight into the clinicopathologic significance of miR-144-3p in hepatocellular carcinoma
Liang HW, Ye ZH, Yin SY, Mo WJ, Wang HL, Zhao JC, Liang GM, Feng ZB, Chen G, Luo DZ
OncoTargets and Therapy 2017, 10:3405-3419
Published Date: 11 July 2017
The diagnostic and prognostic values of Ki-67/MIB-1 expression in thyroid cancer: a meta-analysis with 6,051 cases
Pan DH, Wen DY, Luo YH, Chen G, Yang H, Chen JQ, He Y
OncoTargets and Therapy 2017, 10:3261-3276
Published Date: 3 July 2017
Diagnostic and prognostic roles of IRAK1 in hepatocellular carcinoma tissues: an analysis of immunohistochemistry and RNA-sequencing data from the cancer genome atlas
Ye ZH, Gao L, Wen DY, He Y, Pang YY, Chen G
OncoTargets and Therapy 2017, 10:1711-1723
Published Date: 21 March 2017
Human papillomavirus as a potential risk factor for gastric cancer: a meta-analysis of 1,917 cases
Zeng ZM, Luo FF, Zou LX, He RQ, Pan DH, Chen X, Xie TT, Li YQ, Peng ZG, Chen G
OncoTargets and Therapy 2016, 9:7105-7114
Published Date: 17 November 2016
Effect of DcR3-specific siRNA on cell growth suppression and apoptosis induction in glioma cells via affecting ERK and AKT
Zhang Y, Huang SN, Leng YH, Chen X, Liu TT, Wang HL, Wei FL, Luo DZ, Chen G, Wei ZX
OncoTargets and Therapy 2016, 9:5195-5202
Published Date: 29 August 2016
Lower expressed miR-198 and its potential targets in hepatocellular carcinoma: a clinicopathological and in silico study
Huang WT, Wang HL, Yang H, Ren FH, Luo YH, Huang CQ, Liang YY, Liang HW, Chen G, Dang YW
OncoTargets and Therapy 2016, 9:5163-5180
Published Date: 22 August 2016
Clinicopathological role of miR-30a-5p in hepatocellular carcinoma tissues and prediction of its function with bioinformatics analysis
Huang WT, Chen ZX, He RQ, Wu YZ, Yin SY, Liang XN, Chen G, Yang H, Peng ZG, Yang LH
OncoTargets and Therapy 2016, 9:5061-5071
Published Date: 12 August 2016
Expression and clinicopathological implication of DcR3 in lung cancer tissues: a tissue microarray study with 365 cases
Zhang Y, Luo J, He RQ, Huang WT, Li ZY, Li P, Dang YW, Chen G, Li SK
OncoTargets and Therapy 2016, 9:4959-4968
Published Date: 10 August 2016
Clinicopathological significance of STAT4 in hepatocellular carcinoma and its effect on cell growth and apoptosis
Li JJ, Liang L, Liu YR, Luo YH, Liang XN, Luo DZ, Feng ZB, Dang YW, Yang LH, Chen G
OncoTargets and Therapy 2016, 9:1721-1734
Published Date: 21 March 2016